Clinical studies have identified PPARγ expression as a positive prognostic factor in ductal breast cancer [50] and higher concentrations of PPARγ seem to correlate inversely with grading, size and TNM stage of breast cancer [51, 52]. This evidence concerns the gene PPARG and breast carcinoma.